Pazeo Approval History
Pazeo (olopatadine hydrochloride) is a mast cell stabilizer for the treatment of ocular itching associated with allergic conjunctivitis.
Development History and FDA Approval Process for Pazeo
|Feb 2, 2015||Alcon Receives FDA Approval of Pazeo (olopatadine HCl) Ophthalmic Solution for Allergic Conjunctivitis|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.